Scarica l'app Stockscreener
8.89
0.45%
-0.04
Dopo l'orario di chiusura:
8.81
-0.08
-0.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie
What makes Aurinia Pharmaceuticals Inc. stock price move sharplyEarnings Report Picks With High Returns - jammulinksnews.com
Does Aurinia Pharmaceuticals Inc. stock perform well during market downturnsSuperior portfolio returns - jammulinksnews.com
What is Aurinia Pharmaceuticals Inc. company’s growth strategyAchieve breakthrough profits with expert advice - jammulinksnews.com
Why is Aurinia Pharmaceuticals Inc. stock attracting strong analyst attentionMaximize your portfolio’s earning power - jammulinksnews.com
What is the risk reward ratio of investing in Aurinia Pharmaceuticals Inc. stockGet professional advice for market timing - jammulinksnews.com
Is Aurinia Pharmaceuticals Inc. a growth stock or a value stockAchieve breakthrough investment performance - jammulinksnews.com
Should I hold or sell Aurinia Pharmaceuticals Inc. stock in 2025Skyrocketing returns - jammulinksnews.com
Can Aurinia Pharmaceuticals Inc. stock recover from recent decline200 Percent Gain Alert - metal.it
Aurinia Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - PrintWeekIndia
Will Aurinia Pharmaceuticals Inc. stock split in the near futureMarket-leading growth rates - jammulinksnews.com
What analysts say about Aurinia Pharmaceuticals Inc. stockRapid growth opportunities - Autocar Professional
When is the best time to buy Aurinia Pharmaceuticals Inc. stockSuperior profit margins - jammulinksnews.com
Is Aurinia Pharmaceuticals Inc. a good long term investmentTremendous gains - PrintWeekIndia
What drives Aurinia Pharmaceuticals Inc. stock priceUnmatched profit growth - Autocar Professional
Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Zenopa
Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Aurinia Pharmaceuticals: LUPKYNIS Growth and AUR200 Pipeline Fuel Long-Term Value - AInvest
ISS Recommends That Aurinia Shareholders Vote "FOR" All Proposals at 2025 Annual General Meeting - Yahoo.co
(AUPH) Technical Data - news.stocktradersdaily.com
Aurinia Pharmaceuticals (NASDAQ:AUPH) Delivers Shareholders Favorable 52% Return Over 1 Year, Surging 5.5% in the Last Week Alone - 富途牛牛
1.32%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):